Results 91 to 100 of about 26,273 (196)

Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma Patients

Canadian Journal of Gastroenterology and Hepatology, 2018
Background & Aims. The significance of short-term changes in model for end-stage liver disease and Sodium (MELD-Na) following hepatocellular carcinoma (HCC) diagnosis is unknown.
Justin Y. Tang, Nitin Ohri, Rafi Kabarriti, Santiago Aparo, Jennifer Chuy, Sanjay Goel, Jonathan M. Schwartz, Milan Kinkhabwala, Andreas Kaubisch, Chandan Guha   +9 more
doaj   +1 more source

Comparative evaluation of ALBI, MELD, and Child-Pugh scores in prognosis of cirrhosis: is ALBI the new alternative?

Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology, 2019
Background: The existence of reliable prognostic indices is of paramount importance in the management of cirrhosis. Both the model for end-stage liver disease (MELD) score and the older Child-Pugh (CP) scores are widely used. The albumin-bilirubin (ALBI)
M. Fragaki, D. Sifaki-Pistolla, E. Orfanoudaki, E. Kouroumalis   +3 more
semanticscholar   +1 more source

Determinants of Early Renal Function Recovery After TIPS in Patients With Portal Hypertension

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Renal dysfunction frequently occurs in patients with portal hypertension and is linked to unfavorable clinical outcomes. Transjugular intrahepatic portosystemic shunt (TIPS) has the potential to enhance renal perfusion through portal decompression; however, factors predicting early improvement in renal function remain insufficiently defined ...
Meng Jia, Yang Luo, Zhao‐Yang Tan, Xiao‐Ling Zhou, Xi‐You Zhang, Jing‐Ying Sun, Ye Du   +6 more
wiley   +1 more source

Hyponatremia in Cirrhosis: Comparative Evaluation of MELD and MELD-Na Scores for Predicting Short- and Long-Term Mortality

APIK Journal of Internal Medicine
Background: Hyponatremia is a frequent complication in patients with liver cirrhosis and is associated with increased morbidity and mortality. The model for end-stage liver disease (MELD) score is commonly used to predict prognosis in cirrhosis, but does
Goutami V. Kohir, Nagaraj Kotli
doaj   +1 more source

Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement.

PLoS ONE, 2019
Background/aimsThe MELD score was developed to predict survival after transjugular intrahepatic portosystemic shunt (TIPS) placement. Given changes in practice patterns and development of new prognostic tools in cirrhosis, we aimed to evaluate common ...
Andrew S Allegretti, Nathan E Frenk, Nathan E Frenk, Darrick K Li, Harish Seethapathy, Xavier F Vela Parada, Joshua Long, Paul Endres, Daniel S Pratt, Raymond T Chung, Suvranu Ganguli, Zubin Irani, Kei Yamada   +12 more
doaj   +1 more source

ANALYSIS OF THE SURVIVAL OF CIRRHOTIC PATIENTS ENLISTED FOR LIVER TRANSPLANTATION IN THE PRE- AND POST-MELD ERA IN SOUTHERN BRAZIL

Arquivos de Gastroenterologia, 2014
Context Transplantation is the only cure for decompensated cirrhosis. Model for End-Stage Liver Disease (MELD) is used in liver allocation. Objectives Comparing survival of enlisted populations in pre- and post-MELD eras and estimating their long-term ...
Ângelo Zambam de MATTOS, Angelo Alves de MATTOS, Fernanda Karlinski Fernandes SACCO, Lísia HOPPE, Denise Maria Sarti de OLIVEIRA   +4 more
doaj   +1 more source

A Proof‐of‐Concept Study of Language‐Stratified Assessment for Minimal Hepatic Encephalopathy: Integrating the Animal Naming Test and Serum IL‐6

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Minimal hepatic encephalopathy (MHE) involves subtle cognitive dysfunction and systemic inflammation and is associated with an increased risk of overt hepatic encephalopathy. The Animal Naming Test (ANT1) is a rapid semantic fluency tool for MHE assessment, but its performance across different primary spoken languages remains unclear.
Hsin‐Che Lin, Cheng Jen Chen, Tsung‐Han Wu, Po‐Wen Gu, Chun‐Yi Tsai, Wey‐Ran Lin, Chao‐Wei Hsu, Chun‐Yen Lin, Rong‐Nan Chien, Chien‐Hao Huang, Piero Amodio   +10 more
wiley   +1 more source

Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis

Annals of Hepatology, 2017
Background and aim. The combination of Sofosbuvir (SOF) and Ledipasvir (LDV) has been lead to considerable enhancement of treatment of hepatitis C virus (HCV) genotype 1 infection.
Mohammad Saeid Rezaee-Zavareh, Khashayar Hesamizadeh, Bita Behnava, Seyed Moayed Alavian, Mohammad Gholami-Fesharaki, Heidar Sharafi   +5 more
doaj   +1 more source

Child-Turcotte-Pugh Score, MELD Score and MELD-Na Score as Predictors of Short-Term Mortality among Patients with End-Stage Liver Disease in Northern India

Inflammatory Intestinal Diseases, 2019
Background and Objectives: Child-Turcotte-Pugh (CTP), Model for End-Stage Liver Disease (MELD) and MELD-sodium (MELD-Na) scores are used for predicting disease severity and mortality among patients with end-stage liver disease.
Gagandeep Acharya, R. Kaushik, Rohit A. Gupta, Reshma Kaushik   +3 more
semanticscholar   +1 more source

MELD 3.i: A Bayesian framework for updating the model for end-stage liver disease score

JHEP Reports
Background & Aims: The model for end-stage liver disease (MELD) score has been central to liver transplant (LT) allocation since 2002, with iterative updates culminating in MELD 3.0.
Tomohiro Tanaka, Jennifer C. Lai, David Axelrod, Daniel Sewell   +3 more
doaj   +1 more source